San Francisco, California, January 31, 2018 – Anatomic pathology has a wide usage in detection of various types of life-threatening ailments such as cancer and other contagious illness. This technology is also used in pharmaceutical sector, in order to learn toxicology studies. The pathology technology helps in diagnosis of the diseases that are dependent on the macroscopic, immunologic, microscopic, and molecular scrutiny of tissues and organs in the body. One of the major factor propelling the global anatomic pathology market is the increase in the number of geriatric population, the general rise in global population, and predominance of chronic ailments.
The anatomic pathology market is essentially determined by the capacity of anatomic pathology to recognize abnormalities with a specific end goal to detect the infection and prescribe the treatment. Consequently, anatomic pathology finds broad usage in detecting and managing different sorts of chronic diseases and tumors, that are rising at a notable rate. Apart these, some of the other driving factors of the worldwide anatomic pathology market incorporate rising cases of chronic ailments, rise in healthcare expenses, increase in the number of old age people, along with increased usage and effectiveness of biomarkers for disease diagnosis. Predominance of chronic ailments is soaring currently owing to careless exposure to radiations, and change in lifestyle of people. Besides, according to the World Health Report, these chronic infections are likely to result in over 70% of people collapsing to death, along with 60% of illness burden comprehensively by year 2020. These factors are probably going to improve the development of anatomic pathology market. Apart this, in the developing nations government activities carried out in order to spread awareness about advanced technologies are additionally prone to look good for the anatomic pathology market in these region.
On the basis of geographical regions the global anatomic pathology market is segmented into Asia Pacific, North America, Europe, and rest of the World (ROW). Among these, North America region is foreseen to dominate the other regions in coming years. The major reason for the region to take lead is rise in number of geriatric population, and predominance of chronic illness among the people, accompanied by increased usage of personalized medication, and increase in investments by the government in research and development activities. The key companies are also focusing on the advancement in the technology. The region is trailed by Europe, which is in turn followed by Asia Pacific, and Rest of the World.
The global market for anatomic pathology accounts for a promising future growth in coming years. Based on the types of services and products, the market is divided into services, consumables, and instruments. Among the three, the services segment leads the market. The global anatomic pathology market is stuffed with various global and regional players along with a couple of local firms. This results in highly competitive market scenario wherein organizations are investing heavily into innovative work for disease symptoms that will enable them to remain ahead in the race.
Some of the leading players in the worldwide anatomic pathology market incorporate Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories Inc., Sakura Finetek USA Inc., and F. Hoffmann-La Roche Ltd., among others.
Get Sample Copy of this Report